The FDA has approved the first prescription oral soluble film "for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting."
DRUG(S)
Zuplenz (ondansetron), made by Strativa Pharmaceuticals.
CANCER TYPE(S)
All
HOW DOES IT WORK?
Zuplenz is an oral soluble film, meaning that it's a thin strip that dissolves when the patient puts it on their tongue. The benefits of this delivery system are that the patient doesn't need to drink water, they don't have to swallow anything, and they need not be concerned about whether or not they're taking it on an empty stomach.
SOURCE(S)
PR Newswire
By Ross Bonander
The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
